secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMNICELL, INC. (OMCL)
CIK:        0000926326
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0000926326-24-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omnicell Q3 revenue $282M (-5% YoY); raises FY2024 non-GAAP EBITDA & EPS guidance
--------------------------------------------------------------------------------

- Q3 GAAP net income $9M ($0.19/diluted) vs. $6M ($0.12) YoY; non-GAAP EPS $0.56 vs. $0.62.
- Total revenues $282M, down 5% YoY due to health system headwinds and XT Series cycle timing.
- FY2024 guidance raised: non-GAAP EBITDA $129-134M, non-GAAP EPS $1.65-1.72.
- Appointed Nnamdi Njoku as EVP & COO; cash $571M, $350M revolver undrawn.
- Q4 2024 revenue guidance $295-305M; non-GAAP Q4 EPS $0.55-0.62.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926326/000092632624000030/0000926326-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926326/000092632624000030/omcl-20241030.htm
  HTML page:      https://secwatch.observer/filing/0000926326-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer